10 November 2023FeaturesPatentsSarah Gibbs and Emma Lyons

Weight loss drugs: The impact of NICE and the FDA

In March 2023, the National Institute for Health and Care Excellence (NICE) published guidelines recommending the use of semaglutide for weight management. Semigltuide was officially launched for use in the whole of the UK in September 2023.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Penn State prevails in trademark dispute with Vintage Brand over retro logos

Google: Ex-engineer ‘touted dominion over the trade secrets he stole’

‘Trade secrets can be emotional’: Seth Gerber, Morgan Lewis

Private equity eyes controlling interest in Anaqua

Motorola can’t enforce ‘multiple’ US Hytera damages in UK

UK firms Venner Shipley and AA Thornton combine

Kathi Vidal to rejoin previous firm as partner following USPTO departure

Around the world with trade secrets

Weight loss drugs: The impact of NICE and the FDA

More on this story

Editor's picks

Editor's picks

More articles